Single-dose rasburicase for tumour lysis syndrome in adults: Weight-based approach

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 2, 2009, Pages 207-213

  Campara, M ^a   Shord, S S ^a   Haaf, C M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adult; Rasburicase; Serum urate; Single dose; Tumour lysis syndrome; Urate oxidase

Indexed keywords

ALLOPURINOL; BICARBONATE; RASBURICASE; URATE OXIDASE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; HYDRATION; HYPERURICEMIA; MALE; SINGLE DRUG DOSE; TUMOR LYSIS SYNDROME; URIC ACID BLOOD LEVEL;

AGED; ANTINEOPLASTIC AGENTS; CREATININE; DRUG COSTS; FEMALE; GOUT SUPPRESSANTS; HUMANS; HYPERURICEMIA; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR LYSIS SYNDROME; URATE OXIDASE; URIC ACID;

EID: 61349100786     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00994.x     Document Type: Article

References (20)

1. Cheson BD, Dutcher BS (2005) Managing malignancy-associated hyperuricemia with rasburicase. The Journal of Support Oncology, 3, 117 124.
2. Goldman SC, Holcenberg JS, Finklestein JZ et al. (2001) Randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood, 97, 2998 3003.
3. Browning LA, Kruse JA (2005) Hemolysis and methemoglobinemia secondary to rasburicase administration. Annals of Pharmacotherapy, 39, 1932 1935.
4. Anonymous (2007) Product information: Elitek(R), rasburicase. New York, NY : Sanofi-Aventis.
5. Bosly A, Sonet A, Pinkerton CR, McCowage G, Bron D, Sanz MA, Van den Berg H (2003) Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer, 98, 1048 1054.
6. Coiffier B, Mounier N, Bologna S et al. (2003) Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. Journal of Clinical Oncology, 21, 4402 4406.
7. Jeha S, Kantarjian H, Irwin D et al. (2005) Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia, 19, 34 38.
8. Pui CH, Jeha S, Irwin D, Camitta B (2001) Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. Leukemia, 15, 1505 1509.
9. Anonymous (2006) Red book, 111th edn. Montvale, NJ : Thomson PDR, 800.
10. Coiffier B, Altman A, Pui CH, Younes A, Cairo MS (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. Journal of Clinical Oncology, 26, 2767 2778.
11. Hummel M, Buchheidt D, Reiter S, Bergmann J, Adam K, Hehlmann R (2005) Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. European Journal of Haematology, 75, 518 521.
12. Hutcherson DA, Gammon DC, Bhatt MS, Faneuf M (2006) Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy. Pharmacotherapy, 26, 242 247.
13. Lee AC, Li CH, So KT, Chan R (2003) Treatment of impending tumor lysis with single-dose rasburicase. Annals of Pharmacotherapy, 37, 1614 1617.
14. Liu CY, Sims-McCallum RP, Schiffer CA (2005) A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy. Leukemia Research, 29, 463 465.
15. Trifilio S, Gordon L, Singhal S et al. (2006) Reduceddose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia. Bone Marrow Transplantation, 37, 997 1001.
16. Stapleton FB, Strother DR, Roy S III., Wyatt RJ, McKay CP, Murphy SB (1988) Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics, 82, 863 869.
17. Bowman WP, Shuster JJ, Cook B et al. (1996) Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. Journal of Clinical Oncology, 14, 1252 1261.
18. Atra A, Gerrard M, Hobson R, Imeson JD, Ashley S, Pinkerton CR (1998) Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL) - results of the UKCCSG 9003 protocol. British Journal of Cancer, 77, 2281 2285.
19. McDonnell AM, Lenz KL, Frei-Lahr DA, Hayslip J, Hall PD (2006) Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults. Pharmacotherapy, 26, 806 812.
20. Arnold TM, Reuter JP, Delman BS, Shanholtz CB (2004) Use of single-dose rasburicase in an obese female. Annals of Pharmacotherapy, 38, 1428 1431.